Medtronic Device Repairs Heart Valve With Low Stroke Risk

Medtronic Inc.’s CoreValve replaced damaged aortic valves more safely than expected in patients who can’t tolerate traditional open-heart surgery, leading U.S. regulators to say it won’t need an advisory committee review.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.